Top Markets
Coin of the day
Histogen Inc. Histogen Inc.

Histogen Inc.

HSTO
Rankning i aktier #40870
Histogen Inc. operates as a clinical-stage biotechnology company, focusing on... Histogen Inc. operates as a clinical-stage biotechnology company, focusing on the development of novel, stem cell-free biologic products derived from its proprietary hypoxia-generated growth factor technology platform. Among its offerings is HST-003, a human extracellular matrix, currently undergoing Phase 1/2 clinical trials to mend articular cartilage defects in the knee. Additionally, the company is advancing HST-004, a cell-conditioned media solution designed for spinal disc repair, and Emricasan, an orally active pan-caspase inhibitor targeting COVID-19 treatment. In its preclinical pipeline, Histogen is developing CTS-2090 and CTS-2096. These are selective caspase-1 inhibitors formulated to suppress inflammasome activation and intervene in a range of inflammation-mediated conditions. Founded in 2007, Histogen Inc. maintains its headquarters in San Diego, California.
Aktiekurs
$0.02765
Senast synkroniserad: 2024-12-23
Marknadsvärde
$69.04K
Förändring (1 dag)
0.00%
Förändring (1 år)
0.00%
Land
US
Handel Histogen Inc. (HSTO)

Kategori

P/S-tal för Histogen Inc. (HSTO)
P/S-tal per August 2026 TTM: 0.02
Enligt Histogen Inc. senaste finansiella rapporter och aktiekurs är det aktuella P/S-talet (TTM) 0.02. I slutet av 2021 hade företaget ett P/S-tal på 1.38.
Historik för P/S-tal för Histogen Inc. från 2011 till 2026
P/S-tal vid årets slut
År P/S-tal Ändra
2026 (TTM) 0.02 -67.57%
2022 0.07 -94.87%
2021 1.38 313.79%
2020 0.33 -19.32%
2019 0.41 163.81%
2018 0.16 -58.10%
2017 0.37 -97.50%
2016 14.94 0.00%
2015 0.00 0.00%
2014 0.00 0.00%
2013 0.00 0.00%
2012 0.00 0.00%
2011 0.00 0.00%
P/S-tal för liknande företag eller konkurrenter
Företag P/S-tal Skillnad i P/S-tal Land
9.88 43,427.75%
US
10.30 45,287.67%
NL
- -
CH
- -
KR
4.98 21,835.24%
BE